Articles
| Open Access |
https://doi.org/10.55640/
METABOLIC THERAPY WITH LECIP FORTE IN CHILDREN WITH PERINATAL CENTRAL NERVOUS SYSTEM DAMAGE
Majidova Y.N., Khusenova N.T., Li M.S. , Department of Neurology, Pediatric Neurology, and Medical Genetics, TSMUAbstract
Relevance. Perinatal damage to the central nervous system (CNS) is detected in 10–20% of newborns and remains a significant cause of disability. Metabolic drugs are used in complex therapy, but their effectiveness has not been sufficiently studied.
Keywords
perinatal CNS damage, hypoxic-ischemic encephalopathy, metabolic therapy, pediatric neurology.
References
Novak I., et al. Early intervention in cerebral palsy // JAMA Pediatrics. 2017.
Volpe J.J. Neurology of the Newborn. 6th ed. 2018.
Azzopardi D., et al. Hypothermia in neonatal encephalopathy // N Engl J Med. 2009.
Glass H.C., et al. Outcomes after neonatal HIE // Clin Perinatol. 2016.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.